Functionally, the result of the EdU assay showed that the RAD51 inhibitor B02 significantly decreased the proliferation of CCA cells induced by HMGA1 (Fig. 7A and Fig. S5A). The gene discussed is RAD51; the disease is cholangiocarcinoma.